Results for tag: "Feraheme"

Feraheme (ferumoxytol) is a hematological drug used to treat iron deficiency anemia in adults with chronic kidney disease. It is an intravenous iron replacement therapy that helps to replenish iron stores in the body. Feraheme is the only intravenous iron replacement therapy approved by the U.S. Food and Drug Administration (FDA) for this indication. It is also approved for use in Canada, Europe, and other countries. Feraheme is marketed by Takeda Pharmaceuticals, a global pharmaceutical company based in Japan. Other companies involved in the Feraheme market include Vifor Pharma, a Swiss-based pharmaceutical company, and American Regent, a U.S.-based pharmaceutical company. Additionally, several generic drug manufacturers have developed generic versions of Feraheme. Show Less Read more